Researchers say Hoechst drug may be treatment for cocaine, nicotine addicts

Article Abstract:

Scientists at Brookhaven National Laboratory in Upton, N.Y. found Hoechst Marion Roussel's drug Sabril blocked the effects of cocaine by nearly 50% in rats without major side effects. The drug also stopped animals from seeking out the addictive drug. Sabril is an epilepsy drug widely used in Europe and awaiting approval in the U.S. Dr. Dewey, a scientist and Brookhaven, wants to start clinical tests on cocaine addicts as soon as the drug is approved. There are currently no medications to treat cocaine addiction.

Comment:

Scientists found the drug Sabril blocked effects of cocaine and nicotine

Product development, Company Planning/Goals, Hoechst Marion Roussel Inc., Article

---

Warner-Lambert's Rezulin sales could suffer

Article Abstract:

Warner-Lambert's drug that lowers blood sugar in diabetics, Rezulin, will remain on the market in spite of reports of serious liver damage that often leads to the need for a liver transplant or to death. The company refutes the allegations that it is a one-drug company, meaning Lipitor. Nevertheless, sales of Rezulin will probably decline until SmithKline and Lilly launch newer products for the same indication and then Rezulin's sales are expected to drop even lower.

Comment:

Advantages of the drug outweigh the disadvantages

Sales & consumption, Care and treatment, Safety and security measures, Diabetes, Diabetes mellitus, Warner-Lambert Co., WLA

---

Healthy women can use cancer drug

Article Abstract:

London-based Zeneca Group PLC received U.S. FDA approval for its breast cancer drug Nolvadex for use with women in the high risk category for acquiring the disease. Generically known as tamoxifen, the drug has side effects such that the FDA recommends only high risk women be given the option. Tests on this drug and raloxifene will continue.

United Kingdom, Product information, Anticancer Drugs, Evaluation, Marketing, Prevention, Breast cancer, Antineoplastic agents, United States. Food and Drug Administration, Zeneca Group PLC

Similar abstracts:

• Abstracts: Westpac is poised to test its home cooking on non-bank advisors. Westpac, debt-easy and raring to go
• Abstracts: Aetna launches E-pay to speed claims payment. GE unit to acquire Marquette Medical Oxford CEO details at annual meeting plan to nurse the HMO back to health
• Abstracts: Reader's Digest plans major changes in business structure, executive staff. It isn't a nose dive, but perfume sales are steadily dropping; traditional fragrances fade as trends push shoppers to cheaper, basic smells; from Giorgio to generic
• Abstracts: Apple endorses some achievers who 'think different'. Humor is the catalyst in a new $40 million campaign for Kinko's
• Abstracts: Diabetes study supports drug therapy. Warner-Lambert's de Vink to succeed CEO Goodes, who is retiring early. Warner-Lambert and Glaxo end a venture on ulcer drug Zantac

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.